These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12637374)

  • 1. Tobacco, coffee, and Parkinson's disease.
    Gale C; Martyn C
    BMJ; 2003 Mar; 326(7389):561-2. PubMed ID: 12637374
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk.
    Powers KM; Kay DM; Factor SA; Zabetian CP; Higgins DS; Samii A; Nutt JG; Griffith A; Leis B; Roberts JW; Martinez ED; Montimurro JS; Checkoway H; Payami H
    Mov Disord; 2008 Jan; 23(1):88-95. PubMed ID: 17987647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of caffeine on nicotine's discriminative stimulus, subjective, and reinforcing effects.
    Perkins KA; Fonte C; Stolinski A; Blakesley-Ball R; Wilson AS
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):275-81. PubMed ID: 16366757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coffee and health. The latest buzz.
    Mayo Clin Health Lett; 2012 Jun; 30(6):7. PubMed ID: 22774242
    [No Abstract]   [Full Text] [Related]  

  • 5. Caffeine potentiates the discriminative-stimulus effects of nicotine in rats.
    Gasior M; Jaszyna M; Munzar P; Witkin JM; Goldberg SR
    Psychopharmacology (Berl); 2002 Aug; 162(4):385-95. PubMed ID: 12172692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse.
    Singh S; Singh K; Patel S; Patel DK; Singh C; Nath C; Singh MP
    Brain Res; 2008 May; 1207():193-206. PubMed ID: 18374908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Caffeine as a preventive drug for Parkinson's disease: epidemiologic evidence and experimental support].
    Góngora-Alfaro JL
    Rev Neurol; 2010 Feb 16-28; 50(4):221-9. PubMed ID: 20198594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cigarette and coffee--pharmacokinetics interaction between nicotine and caffeine].
    Florek E; Enko J; Piekoszewski W
    Przegl Lek; 2009; 66(10):866-8. PubMed ID: 20301956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is nicotine addiction an answer or a question?
    Slama K
    Int J Tuberc Lung Dis; 2003 Sep; 7(9):809-10. PubMed ID: 12971662
    [No Abstract]   [Full Text] [Related]  

  • 10. Smoking tobacco, microcirculatory changes and the role of nicotine.
    Haustein KO
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):76-85. PubMed ID: 10082171
    [No Abstract]   [Full Text] [Related]  

  • 11. What's new in nicotine & tobacco research?
    Hébert Eb R
    Nicotine Tob Res; 2004 Apr; 6(2):191-8. PubMed ID: 15203792
    [No Abstract]   [Full Text] [Related]  

  • 12. [Should coffee be classified as a doping agent? Caffeine is definitely effective when it comes to performance capacity].
    Fredholm BB
    Lakartidningen; 1995 Nov; 92(44):4079-80. PubMed ID: 8538271
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nicotine and caffeine: influence on dopaminergic transmission].
    Napierała M; Bogusiewicz J; Enko J; Florek E
    Przegl Lek; 2016; 73(10):791-4. PubMed ID: 29689686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tobacco use disorder and use of nicotine substitutes during pregnancy and post-partum].
    Cornuz J; Wirthner D; Zellweger JP
    Rev Med Suisse Romande; 2002 Jun; 122(6):305-7. PubMed ID: 12174692
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tobacco addiction. Epidemiology and pathology associated with tobacco].
    Dautzenberg B; Lagrue G
    Rev Prat; 2001 Apr; 51(8):877-82. PubMed ID: 11387692
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
    Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):486-94. PubMed ID: 11160635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson's disease through an NRF2-dependent mechanism.
    Trinh K; Andrews L; Krause J; Hanak T; Lee D; Gelb M; Pallanck L
    J Neurosci; 2010 Apr; 30(16):5525-32. PubMed ID: 20410106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a negative association between anxiety sensitivity and arousal-increasing substances and activities?
    McWilliams LA; Asmundson GJ
    J Anxiety Disord; 2001; 15(3):161-70. PubMed ID: 11442136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of smokeless tobacco extract on catecholamine metabolic enzymes in rat brain: "dippers" are getting only half of the bang.
    Alford GS; Szebeni K; Klimek V; Piletz JE; Orr S; Ordway GA
    Addict Behav; 2006 Aug; 31(8):1503-9. PubMed ID: 16487666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.